Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Tirzepatide & Adiposity / Obesity, the FDA has approved tirzepatide for long-term managing Adiposity / Obesity in adults and have at least one other health issue related to weight.The FDA's decision was mainly based on the SURMOUNT‑1 and SURMOUNT‑2 studies. These showed that people lost about 15–20% of their body weight at the highest doses after 72 weeks. This was much more than those who took a placebo, especially in adults who were obese or overweight with other health issues (1).